NeuroGeneces
Applies neurotech to sleeping time to improve memory .
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | €0.0 | round |
* | $100k | Grant | |
| Total Funding | 000k | ||
Related Content
NeuroGeneces, founded in 2016 by Karen Crow and Dr. Jason Worchel, is a neurotechnology company focused on the early detection of cognitive decline. The company's creation was deeply rooted in personal experience; Crow, a former Google executive, was motivated by her mother's battle with Alzheimer's and her son's sleep disorder. This led her to discover the critical link between sleep, particularly slow-wave sleep, and brain health. She partnered with Dr. Worchel, a neuropsychiatrist with expertise in neurostimulation, to establish the company.
Operating from Santa Fe, New Mexico, NeuroGeneces is developing technology to bring clinical-grade brain health monitoring into the home. The company's flagship product is the NeuroInsight™ assessment, an AI-driven platform that uses a wearable sleep headband to monitor brain activity. This non-invasive device collects clinical-grade data, including EEG, pulse oximetry, and heart rate variability, during sleep. Proprietary machine-learning algorithms then analyze this data, converting it into over 50 biomarkers to determine a person's "Brain Age" by comparing their neurophysiology against a large database of healthy adults. This process aims to detect early signs of atypical brain decline years before cognitive symptoms manifest, enabling timely lifestyle and behavioral interventions.
The business model targets physicians, who can recommend the NeuroInsight™ assessment to their patients. Following a physician's recommendation, a kit is shipped directly to the patient, who wears the headband for several nights before returning it. A detailed report is then sent to the physician to discuss with the patient. NeuroGeneces has secured over $5.4 million in funding through multiple rounds, including grants from the National Science Foundation and support from accelerators like Techstars and MassChallenge. The company holds a granted patent with others pending and has validated its AI and headband technology in university-based studies.
Keywords: NeuroGeneces, brain health monitoring, NeuroInsight, early cognitive decline detection, sleep science, neurotechnology, wearable EEG, Brain Age, neurodegeneration, preventative neurology, Karen Crow, Jason Worchel, AI health assessment, home sleep test, neurostimulation, slow-wave sleep, cognitive performance, memory consolidation, brain biomarkers, digital health